Gruthan Bioscience receives funding to develop a novel class of cholesterol-lowering drugs
Gruthan Bioscience was recently awarded funding to develop a novel class of cholesterol-lowering drugs to treat a rare form of familial hypercholesterolemia; It could one...
















